Cargando…

Adequate tacrolimus exposure modulates the impact of HLA class II molecular mismatch: a validation study in an American cohort

Clinicians have few tools to predict the risk of alloimmune injury that would guide immunosuppression management in renal transplant patients. We evaluated human leukocyte antigen (HLA)‐DR/DQ molecular mismatch to predict de novo donor‐specific antibodies (DSAs) during the first year of transplant a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Davis, Scott, Wiebe, Christopher, Campbell, Kristen, Anobile, Cheri, Aubrey, Michael, Stites, Erik, Grafals, Monica, Pomfret, Elizabeth, Nickerson, Peter, Cooper, James E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Brief Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7821185/ https://www.ncbi.nlm.nih.gov/pubmed/32888256 http://dx.doi.org/10.1111/ajt.16290

Ejemplares similares

A Comparison of HLA Molecular Mismatch Methods to Determine HLA Immunogenicity
por: Wiebe, Chris, et al.
Publicado: (2018)

Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients
por: Lee, Hyeyoung, et al.
Publicado: (2022)

HLA‐DR/DQ molecular mismatch: A prognostic biomarker for primary alloimmunity
por: Wiebe, Chris, et al.
Publicado: (2018)

Does the Tacrolimus Trough Level Adequately Predict Drug Exposure in Patients Requiring a High Tacrolimus Dose?
por: Haverals, Lien, et al.
Publicado: (2023)

Reducing disparities in kidney transplantation for Spanish-speaking patients through creation of a dedicated center
por: Pande, Madhura, et al.
Publicado: (2022)

The Immunogenicity of HLA Class II Mismatches: The Predicted Presentation of Nonself Allo-HLA-Derived Peptide by the HLA-DR Phenotype of the Recipient Is Associated with the Formation of DSA
por: Jucaud, Vadim
Publicado: (2017)

The Association Between Broad Antigen HLA Mismatches, Eplet HLA Mismatches and Acute Rejection After Kidney Transplantation
por: Do Nguyen, Hung Thanh, et al.
Publicado: (2016)

Proteogenomic identification of an immunogenic HLA class I neoantigen in mismatch repair–deficient colorectal cancer tissue
por: Hirama, Tomomi, et al.
Publicado: (2021)

Soluble HLA Technology as a Strategy to Evaluate the Impact of HLA Mismatches
por: Kunze-Schumacher, Heike, et al.
Publicado: (2014)

HLA Haplotype Mismatch Transplants and Posttransplant Cyclophosphamide
por: Bacigalupo, Andrea, et al.
Publicado: (2016)

Impact of HLA class I allele-level mismatch on viral infection within 100 days after cord blood transplantation
por: Iemura, Tomoki, et al.
Publicado: (2020)

T-replete HLA-matched grafts vs T-depleted HLA-mismatched grafts in inborn errors of immunity
por: Lum, Su Han, et al.
Publicado: (2022)

Distinctive DNA mismatch repair and APC rare variants in African Americans with colorectal neoplasia
por: Ashktorab, Hassan, et al.
Publicado: (2017)

Performance of HLA allele prediction methods in African Americans for class II genes HLA-DRB1, −DQB1, and –DPB1
por: Levin, Albert M, et al.
Publicado: (2014)

Donor-Derived Cell-Free DNA at 1 Month after Kidney Transplantation Relates to HLA Class II Eplet Mismatch Load
por: González-López, Elena, et al.
Publicado: (2023)

The CoGenT3 Study: Cognition and Gender Trends in Three American Generations
por: Stites, Shana
Publicado: (2020)

Evaluation of the Safety and Effectiveness of Add-On Tacrolimus in Patients with Rheumatoid Arthritis Who Failed to Show an Adequate Response to Biological DMARDs: The Interim Results of a Specific Drug Use-Results Survey of Tacrolimus
por: Ishida, Kota, et al.
Publicado: (2015)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)

HLA class II gene associations in African American Type 1 diabetes reveal a protective HLA-DRB1*03 haplotype
por: Howson, J M M, et al.
Publicado: (2013)

Allorecognition of HLA-C Mismatches by CD8(+) T Cells in Hematopoietic Stem Cell Transplantation Is a Complex Interplay between Mismatched Peptide-Binding Region Residues, HLA-C Expression, and HLA-DPB1 Disparities
por: Bettens, Florence, et al.
Publicado: (2016)

HLA-mismatched hematopoietic stem cell tranplantation for pediatric solid tumors
por: Pession, Andrea, et al.
Publicado: (2011)

Indirectly Recognized HLA-C Mismatches and Their Potential Role in Transplant Outcome
por: Thus, Kirsten A., et al.
Publicado: (2014)

HLA Mismatching Strategies for Solid Organ Transplantation – A Balancing Act
por: Zachary, Andrea A., et al.
Publicado: (2016)

Association between CTL Precursor Frequency to HLA-C Mismatches and HLA-C Antigen Cell Surface Expression
por: Israeli, Moshe, et al.
Publicado: (2014)

HLA class II transgenic mice: the chance to unravel the basis of HLA class II associations with disease
Publicado: (1994)

Association of HLA-A and Non-Classical HLA Class I Alleles
por: Carlini, Federico, et al.
Publicado: (2016)

Daratumumab for donor-specific anti-HLA antibody desensitization in a case of HLA-mismatched allogeneic stem cell transplantation
por: Ibrahim, Uroosa, et al.
Publicado: (2023)

HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patients
por: Xu, Ruonan, et al.
Publicado: (2021)

Genotype-guided tacrolimus dosing in African American kidney transplant recipients
por: Sanghavi, K., et al.
Publicado: (2015)

Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule
Publicado: (1990)

Expression of HLA Class I and HLA Class II by Tumor Cells in Chinese Classical Hodgkin Lymphoma Patients
por: Huang, Xin, et al.
Publicado: (2010)

HLA class II regulation and structure. Analysis with HLA-DR3 and HLA-DP point mutants
Publicado: (1985)

The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors
por: Koclega, Anna, et al.
Publicado: (2012)

Pretransplant active disease status and HLA class II mismatching are associated with increased incidence and severity of cytokine release syndrome after haploidentical transplantation with posttransplant cyclophosphamide
por: Mariotti, Jacopo, et al.
Publicado: (2019)

HLA-Clus: HLA class I clustering based on 3D structure
por: Shen, Yue, et al.
Publicado: (2023)

Influence of HLA class I, HLA class II and KIRs on vertical transmission and chronicity of hepatitis C virus in children
por: Ruiz-Extremera, A., et al.
Publicado: (2017)

Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemia
por: Punwani, Nathan, et al.
Publicado: (2018)

Increased age-associated mortality risk in HLA-mismatched hematopoietic stem cell transplantation
por: Fürst, Daniel, et al.
Publicado: (2017)

HLA Eplet Mismatches in Kidney Transplantation: More Than Just Adding Things Up
por: Sypek, Matthew P., et al.
Publicado: (2021)

Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration
por: Kashani, Amir H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fskrppqteijl4vkqitb5k18cd7